WCLC 2023| Dr. Wang Jie Awarded the 2023 Small Cell Lung Cancer Heine H. Hansen Award

WCLC 2023| Dr. Wang Jie Awarded the 2023 Small Cell Lung Cancer Heine H. Hansen Award

2024.01.19
The International Association for the Study of Lung Cancer (IASLC) annually presents several awards to clinical physicians and researchers who have made significant contributions to the treatment of lung cancer patients. Awardees are invited to receive their awards at the World Conference on Lung Cancer (WCLC) and give speeches in their respective fields. At the WCLC 2023 conference, these awards were presented for the first time in a dedicated plenary session titled "Plenary Session 2: IASLC Lectureship Award Presentations," jointly hosted by IASLC CEO Karen Kelly and IASLC President Heather Wakelee. The Lectureship awards are presented to members from various fields, including radiation oncology, medical oncology, small cell lung cancer, nursing/health, translational research, thoracic surgery, staging, and tobacco control. Dr. Wang Jie from the Cancer Hospital Chinese Academy of Medical Sciences was awarded the 2023 Small Cell Lung Cancer Heine H. Hansen Lectureship Award for her outstanding contributions to small cell lung cancer research and treatment.
WCLC 2023 | Dr. Ramalingam Shares Wining Statement as a Winner of the IASLC Scientific Award

WCLC 2023 | Dr. Ramalingam Shares Wining Statement as a Winner of the IASLC Scientific Award

2024.01.19
The Paul A. Bunn, Jr. Scientific Award, bestowed by IASLC, aims to honor the lifelong scientific contributions of IASLC scientists to thoracic cancer research. Dr. Ramalingam's research focuses on developing new treatment strategies for lung cancer patients. His team developed innovative treatment regimens for lung cancer patients with EGFR mutations, which led to the FDA's approval of a third-generation EGFR inhibitor for metastatic non-small cell lung cancer. Additionally He also led clinical and translational research on new immunotherapies for treating lung cancer , resulting in over 400 published, peer-reviewed publications. He also served on the IASLC board of directors (2017-2021) and the NCI Thoracic Malignancy Steering Committee (2012-2021). He is currently the chief editor of the journal 《Cancer》 published by the American Society of Clinical Oncology.